Latest news with #SGD43.35M
Yahoo
09-07-2025
- Business
- Yahoo
July 2025's Top Asian Penny Stocks
As of July 2025, the Asian markets are navigating a complex landscape marked by trade negotiations and economic data that reflect both challenges and opportunities. For investors looking to explore beyond established giants, penny stocks—though an older term—remain a relevant area for potential growth. These smaller or newer companies can offer surprising value when backed by solid financial foundations, and this article will highlight three such stocks that demonstrate financial strength in today's market conditions. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.102 SGD43.35M ★★★★★★ Lever Style (SEHK:1346) HK$1.36 HK$858.09M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.17 HK$1.81B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.425 SGD172.25M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.13 HK$1.89B ★★★★★★ T.A.C. Consumer (SET:TACC) THB4.44 THB2.66B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.28 SGD8.97B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.93 THB1.37B ★★★★★★ BRC Asia (SGX:BEC) SGD3.30 SGD905.36M ★★★★★★ United Energy Group (SEHK:467) HK$0.53 HK$13.7B ★★★★★★ Click here to see the full list of 988 stocks from our Asian Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Uju Holding Limited is an investment holding company that offers digital marketing services and live-streaming e-commerce in the People's Republic of China, with a market capitalization of approximately HK$2.19 billion. Operations: The company generated CN¥9.15 billion from its All-In-One Online Marketing Solutions Services segment. Market Cap: HK$2.19B Uju Holding Limited, with a market capitalization of approximately HK$2.19 billion, has experienced significant volatility in its share price recently. The company generated CN¥9.15 billion from its All-In-One Online Marketing Solutions Services segment, indicating substantial revenue streams. However, earnings have declined by 15.9% annually over the past five years, though recent growth of 3.7% outpaces industry averages. Recent leadership changes include Mr. Cheng Yu and Ms. Ma Xiaoxia assuming key roles; they also acquired a controlling stake in the company for HKD 210 million and are pursuing additional shares to consolidate ownership further. Click to explore a detailed breakdown of our findings in Uju Holding's financial health report. Gain insights into Uju Holding's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sihuan Pharmaceutical Holdings Group Ltd. is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in China, with a market cap of approximately HK$10.41 billion. Operations: The company's revenue is primarily derived from its Generic Medicine segment, generating CN¥1.10 billion, followed by Medical Aesthetic Products at CN¥744.22 million and Innovative Medicine and Other Medicine contributing CN¥109.67 million. Market Cap: HK$10.41B Sihuan Pharmaceutical Holdings Group, with a market cap of HK$10.41 billion, primarily generates revenue from its Generic Medicine segment (CN¥1.10 billion). Despite being unprofitable, the company has reduced losses by 5.3% annually over five years and maintains a strong cash position exceeding its total debt. Recent developments include the acceptance of a new drug application for Bireociclib Tablets targeting breast cancer and approval for Dapagliflozin Tablets in diabetes treatment, underscoring robust R&D capabilities. The company's medical aesthetic segment is poised for growth following regulatory approvals for innovative PLLA fillers in China's burgeoning market. Take a closer look at Sihuan Pharmaceutical Holdings Group's potential here in our financial health report. Explore historical data to track Sihuan Pharmaceutical Holdings Group's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: AGTech Holdings Limited is an integrated technology and services company operating in the People's Republic of China and Macau, with a market cap of HK$2.65 billion. Operations: The company's revenue is derived from three main segments: Electronic Payment and Related Services (HK$307.26 million), Lottery Operation (HK$239.95 million), and Banking Business (HK$67.76 million). Market Cap: HK$2.65B AGTech Holdings, with a market cap of HK$2.65 billion, operates across electronic payments, lottery operations, and banking in China and Macau. Despite being unprofitable, the company has reduced its losses by 39.3% annually over five years and remains debt-free with short-term assets (HK$4.2 billion) covering both short- and long-term liabilities. Recent earnings reported sales of HK$614.97 million for FY2025 but a net loss of HK$90.43 million due to factors like fair value losses on joint venture loans and decreased revenue from digital payments amid lower tourist spending in Macau post-COVID subsidies ending in 2023. Dive into the specifics of AGTech Holdings here with our thorough balance sheet health report. Understand AGTech Holdings' track record by examining our performance history report. Get an in-depth perspective on all 988 Asian Penny Stocks by using our screener here. Ready For A Different Approach? AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1948 SEHK:460 and SEHK:8279. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-07-2025
- Business
- Yahoo
Asian Penny Stocks To Watch In July 2025
As global markets show mixed performances, with the U.S. indices reaching record highs and Japan facing trade negotiation challenges, Asia's financial landscape remains a focal point for investors. In this context, penny stocks—often representing smaller or newer companies—continue to capture attention due to their potential for growth at accessible price points. Despite being an older term, these stocks can offer significant opportunities when backed by strong financials and solid fundamentals. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.102 SGD43.35M ★★★★★★ Lever Style (SEHK:1346) HK$1.37 HK$864.4M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.22 HK$1.85B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.425 SGD172.25M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.13 HK$1.89B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.92 THB1.35B ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.225 SGD45.5M ★★★★★★ BRC Asia (SGX:BEC) SGD3.25 SGD891.64M ★★★★★★ United Energy Group (SEHK:467) HK$0.52 HK$13.44B ★★★★★★ Click here to see the full list of 987 stocks from our Asian Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Shengmu Organic Milk Limited is an investment holding company involved in the production and distribution of raw milk and dairy products in the People's Republic of China, with a market cap of HK$2.35 billion. Operations: The company generates revenue from its Dairy Farming Business, which amounted to CN¥3.13 billion. Market Cap: HK$2.35B China Shengmu Organic Milk's financial health presents a mixed picture for investors considering penny stocks. While the company has a satisfactory net debt to equity ratio of 37.4% and its interest payments are well covered by EBIT, it remains unprofitable with negative return on equity and declining earnings over the past five years. Short-term liabilities exceed assets, though long-term liabilities are covered. The management team is experienced, which may provide stability amid financial challenges. Recent events include an annual general meeting scheduled for June 2025 to discuss audited financials and director re-elections, reflecting ongoing corporate governance activities. Click here and access our complete financial health analysis report to understand the dynamics of China Shengmu Organic Milk. Assess China Shengmu Organic Milk's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Travel International Investment Hong Kong Limited offers travel and tourism services with a market cap of HK$9.19 billion. Operations: The company generates revenue from several segments, including Tourist Attraction and Related Operations (HK$2.35 billion), Passenger Transportation Operations (HK$1.09 billion), Hotel Operations (HK$820.65 million), and Travel Document and Related Operations (HK$344.02 million). Market Cap: HK$9.19B China Travel International Investment Hong Kong Limited offers a complex investment outlook for penny stock investors. The company has experienced management and board teams, with an average tenure of 2.7 and 5.5 years, respectively. Despite having more cash than debt, its net profit margin has decreased from 5.3% to 2.3%, partly due to a large one-off loss of HK$223.5 million in the last year, impacting earnings quality. Short-term assets exceed both short- and long-term liabilities significantly, providing financial stability despite increased share price volatility and negative recent earnings growth of -55.8%. Click to explore a detailed breakdown of our findings in China Travel International Investment Hong Kong's financial health report. Gain insights into China Travel International Investment Hong Kong's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Boustead Singapore Limited is an investment holding company that offers energy engineering, real estate, geospatial, and healthcare technology solutions across various regions including Singapore, Australia, and the United States, with a market capitalization of SGD762.01 million. Operations: There are no specific revenue segments reported for Boustead Singapore Limited. Market Cap: SGD762.01M Boustead Singapore Limited presents a mixed investment case for penny stock investors. The company demonstrates strong financial stability, with short-term assets surpassing both short- and long-term liabilities significantly, and more cash than total debt. Earnings have grown by 48.1% over the past year, supported by a substantial one-off gain of SGD31.1 million, though revenue declined from SGD767.57 million to SGD527.1 million year-on-year. Despite low return on equity at 16.8%, Boustead's debt is well-covered by operating cash flow and it has proposed higher dividends for 2025 compared to the previous year, reflecting confidence in future cash flows despite an unstable dividend track record. Get an in-depth perspective on Boustead Singapore's performance by reading our balance sheet health report here. Evaluate Boustead Singapore's historical performance by accessing our past performance report. Reveal the 987 hidden gems among our Asian Penny Stocks screener with a single click here. Want To Explore Some Alternatives? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1432 SEHK:308 and SGX:F9D. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
24-06-2025
- Business
- Yahoo
3 Asian Penny Stocks With Market Caps Under US$500M
As global markets navigate a complex landscape marked by geopolitical tensions and fluctuating economic indicators, investors are increasingly turning their attention to smaller-cap stocks. Penny stocks, often associated with smaller or newer companies, continue to attract interest due to their potential for growth at lower price points. Despite being an outdated term, penny stocks can offer significant opportunities when backed by strong financials and solid fundamentals. In this article, we explore several Asian penny stocks that stand out as hidden gems in the current market environment. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.102 SGD43.35M ★★★★★★ Lever Style (SEHK:1346) HK$1.28 HK$807.62M ★★★★★★ KPa-BM Holdings (SEHK:2663) HK$0.335 HK$186.57M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.42 SGD170.22M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.14 HK$1.9B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.22 SGD8.74B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.173 SGD34.46M ★★★★★★ BRC Asia (SGX:BEC) SGD3.10 SGD850.49M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.76 HK$54.53B ★★★★★★ United Energy Group (SEHK:467) HK$0.52 HK$13.44B ★★★★★★ Click here to see the full list of 1,016 stocks from our Asian Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Jacobio Pharmaceuticals Group Co., Ltd. is an investment holding company focused on the in-house discovery and development of oncology therapies, with a market cap of HK$3.86 billion. Operations: The company's revenue is primarily derived from the research and development of new drugs, amounting to CN¥155.71 million. Market Cap: HK$3.86B Jacobio Pharmaceuticals Group, with a market cap of HK$3.86 billion, remains pre-revenue and unprofitable but shows promise through its oncology-focused pipeline. The recent approval of its KRAS G12C inhibitor, glecirasib, for non-small cell lung cancer marks a significant milestone, triggering a RMB 50 million payment from partner Allist Pharmaceuticals. Despite high share price volatility and negative return on equity (-16.87%), Jacobio's strong cash position exceeds total debt and covers liabilities comfortably. Ongoing clinical trials in multiple regions highlight potential growth avenues as the company advances innovative cancer therapies across various signaling pathways. Click here and access our complete financial health analysis report to understand the dynamics of Jacobio Pharmaceuticals Group. Evaluate Jacobio Pharmaceuticals Group's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Midland Holdings Limited is an investment holding company offering property agency services in Hong Kong, Macau, and Mainland China with a market cap of HK$1.05 billion. Operations: The company generates revenue primarily from its property agency services, with HK$6.02 billion coming from residential properties and HK$46.57 million from commercial, industrial properties, and shops. Market Cap: HK$1.05B Midland Holdings, with a market cap of HK$1.05 billion, has shown strong financial performance recently by reporting HK$6.08 billion in sales for 2024, marking significant growth from the previous year. The company's profitability is underscored by a net income of HK$320.32 million and high-quality earnings, supported by robust short-term assets exceeding liabilities. Despite no debt concerns and stable volatility, insider selling has been notable over the past quarter. The recent termination and renewal of its Cross Referral Services Framework Agreement indicate strategic adjustments to capitalize on stronger-than-expected estate agency performance while maintaining compliance with listing rules. Dive into the specifics of Midland Holdings here with our thorough balance sheet health report. Assess Midland Holdings' future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Q & M Dental Group (Singapore) (SGX:QC7) is an investment holding company that offers private dental healthcare services in the People's Republic of China, with a market capitalization of S$387.91 million. Operations: The company's revenue is derived from its Core Dental Business, which generated S$173.79 million, and Other Businesses, contributing S$6.89 million. Market Cap: SGD387.91M Q & M Dental Group (Singapore), with a market capitalization of S$387.91 million, has experienced earnings growth of 27.1% over the past year, surpassing its five-year average decline. The company's net profit margin improved to 8.1%, and it trades at a significant discount to estimated fair value. Although short-term assets cover liabilities, long-term liabilities remain uncovered by these assets. Recent share buyback initiatives indicate strategic capital allocation, while changes in the board suggest evolving governance dynamics. Despite stable weekly volatility and satisfactory debt levels, high-quality earnings are impacted by a large one-off loss of S$5.2 million last year. Click to explore a detailed breakdown of our findings in Q & M Dental Group (Singapore)'s financial health report. Learn about Q & M Dental Group (Singapore)'s future growth trajectory here. Click through to start exploring the rest of the 1,013 Asian Penny Stocks now. Searching for a Fresh Perspective? Uncover 16 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:1167 SEHK:1200 and SGX:QC7. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
